SPIRONOLACTONE FURTHER REDUCES URINARY ALBUMIN EXCRETION AND PLASMA B-TYPE NATRIURETIC PEPTIDE LEVLES IN HYPERTENSIVE TYPE II DIABETES TREATED WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITOR

Natriuretic Peptide ◽

Type Ii Diabetes ◽

Enzyme Inhibitor ◽

Urinary Albumin ◽

Type Ii ◽

Converting Enzyme ◽

Predictors of Angiotensin-Converting Enzyme Inhibitor–Induced Reduction of Urinary Albumin Excretion in Nondiabetic Patients

Hypertension ◽

10.1161/01.hyp.0000244082.26293.2d ◽

2006 ◽

Vol 48 (5) ◽

pp. 870-876 ◽

Cited By ~ 13

Author(s):

Ruud M.A. van de Wal ◽

Ron T. Gansevoort ◽

Pim van der Harst ◽

Frans Boomsma ◽

H.W. Thijs Plokker ◽

...

Keyword(s):

Enzyme Inhibitor ◽

Urinary Albumin ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

Albumin Excretion

Effect of Combination Therapy of Angiotensin-Converting Enzyme Inhibitor plus Calcium Channel Blocker on Urinary Albumin Excretion in Hypertensive Microalubuminuric Patients with Type II Diabetes.

Hypertension Research ◽

10.1291/hypres.23.219 ◽

2000 ◽

Vol 23 (3) ◽

pp. 219-226 ◽

Cited By ~ 21

Author(s):

Toshikatsu SHIGIHARA ◽

Atsuhisa SATO ◽

Koichi HAYASHI ◽

Takao SARUTA

Keyword(s):

Combination Therapy ◽

Calcium Channel ◽

Type Ii Diabetes ◽

Channel Blocker ◽

Enzyme Inhibitor ◽

Urinary Albumin ◽

Type Ii ◽

Converting Enzyme

The Correlation of Brain Natriuretic Peptide (BNP), Pulmonary Arterial Pressure, and St. George Respiratory Questionnaire (SGRQ) and Their Changes with a Trial of an Angiotensin Converting Enzyme Inhibitor

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2010.68.5.273 ◽

2010 ◽

Vol 68 (5) ◽

pp. 273 ◽

Cited By ~ 1

Author(s):

Myung-A Kim ◽

Deog-Kyeom Kim ◽

Chang-Hoon Lee ◽

Hee Soon Chung

Keyword(s):

Arterial Pressure ◽

Brain Natriuretic Peptide ◽

Natriuretic Peptide ◽

Pulmonary Arterial Pressure ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

Pulmonary Arterial

Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.

Heart ◽

10.1136/hrt.72.6.528 ◽

1994 ◽

Vol 72 (6) ◽

pp. 528-533 ◽

Cited By ~ 48

Author(s):

M Yoshimura ◽

H Yasue ◽

H Tanaka ◽

K Kikuta ◽

H Sumida ◽

...

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Natriuretic Peptide ◽

Enzyme Inhibitor ◽

Plasma Concentrations ◽

Converting Enzyme ◽

Effectiveness of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker on Atrial Natriuretic Peptide

Circulation Journal ◽

10.1253/circj.67.1053 ◽

2003 ◽

Vol 67 (12) ◽

pp. 1053-1058 ◽

Cited By ~ 8

Author(s):

Naoyuki Sata ◽

Yasuhiro Tanaka ◽

Syusaku Suzuki ◽

Ryouzou Kamimura ◽

Hiroharu Mifune ◽

...

Keyword(s):

Angiotensin Ii ◽

Atrial Natriuretic Peptide ◽

Natriuretic Peptide ◽

Enzyme Inhibitor ◽

Angiotensin Ii Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Ambulatory blood pressure and urinary albumin excretion in diabetic (non–insulin-dependent and insulin-dependent) hypertensive patients Relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolapril

American Journal of Hypertension ◽

10.1016/s0895-7061(98)00118-6 ◽

1998 ◽

Vol 11 (9) ◽

pp. 1065-1073 ◽

Cited By ~ 15

Author(s):

B BAUDUCEAU ◽

N GENES ◽

B CHAMONTIN ◽

L VAUR ◽

M RENAULT ◽

...

Keyword(s):

Blood Pressure ◽

Ambulatory Blood Pressure ◽

Enzyme Inhibitor ◽

Urinary Albumin ◽

Converting Enzyme ◽

Hypertensive Patients ◽

Insulin Dependent

Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-β, and nitrite excretion

BMC Nephrology ◽

10.1186/1471-2369-3-2 ◽

2002 ◽

Vol 3 (1) ◽

Cited By ~ 15

Author(s):

Liora Adler ◽

Roy Mathew ◽

Stephen Futterweit ◽

Rachel Frank ◽

Bernard G Gauthier ◽

...

Keyword(s):

Alport Syndrome ◽

Enzyme Inhibitor ◽

Urinary Albumin ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.

Heart ◽

10.1136/hrt.73.6.584-b ◽

1995 ◽

Vol 73 (6) ◽

pp. 584-585

Author(s):

B. Cheung

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Natriuretic Peptide ◽

Enzyme Inhibitor ◽

Plasma Concentrations ◽

Converting Enzyme ◽

Angiotensin converting enzyme inhibitor potentiated the vasorelaxant response of atrial natriuretic peptide in toad aortic rings

Comparative Biochemistry and Physiology Part C Comparative Pharmacology ◽

10.1016/0742-8413(90)90126-t ◽

1990 ◽

Vol 95 (2) ◽

pp. 327-332 ◽

Cited By ~ 1

Author(s):

M.Peral de Bruno ◽

A. Coviello

Keyword(s):

Atrial Natriuretic Peptide ◽

Natriuretic Peptide ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

Atrial Natriuretic

3646 Angiotensin-converting enzyme inhibitor therapy reduces the vascular oxidative state in patients with newly diagnosed type II diabetes mellitus

European Heart Journal ◽

10.1016/s0195-668x(03)96230-0 ◽

2003 ◽

Vol 24 (5) ◽

pp. 712

Author(s):

B KHAN

Keyword(s):

Diabetes Mellitus ◽

Type Ii Diabetes ◽

Enzyme Inhibitor ◽

Type Ii Diabetes Mellitus ◽

Type Ii ◽

Converting Enzyme ◽

Newly Diagnosed ◽

Oxidative State